Androstenediol (BioCAD00000006570)
feces adipose tissue adrenal cortex prostate skeletal muscle testis
Metabolite Card
Formula: C19H30O2 (290.2246)
SMILES: [H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@H](O)CC[C@]12C
Synonyms [en]
Androstenediol; 5-Androstenediol; Androst-5-ene-3beta,17beta-diol; Hermaphrodiol; androst-5-en-3beta,17beta-diol; 3beta,17beta-Dihydroxyandrost-5-ene
Last reviewed on 2024-06-28.
Cite this Page
Androstenediol. 数据之源,洞见之始. SMRUCC genomics institute, a synthetic life researcher from China.
https://biocad_registry.innovation.ac.cn/s/(-)-arctiin
(retrieved
2026-01-03) (CAD Registry RN: BioCAD00000006570). Licensed
under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).
Note
5-Androstenediol is a direct metabolite of the most abundant steroid produced by the human adrenal cortex, dehydroepiandrosterone (DHEA). 5-Androstenediol is less androgenic than 4-androstenediol, and stimulates the immune system. When administered to rats in vivo, 5-androstenediol has approximately 1/70 the androgenicity of DHEA, 1/185 the androgenicity of androstenedione, and 1/475 the androgenicity of testosterone (Wikipedia). Because it induces production of white blood cells and platelets, 5-androstenediol is being developed as a radiation countermeasure as Neumune (HE2100). An intermediate in testosterone biosynthesis, found in the testis or the adrenal glands. 5-Androstenediol, derived from dehydroepiandrosterone by the reduction of the 17-keto group (17-hydroxysteroid dehydrogenases), is converted to testosterone by the oxidation of the 3-beta hydroxyl group to a 3-keto group (3-fydroxysteroid dehydrogenase).
DBLinks
- CAS Registry Number: 521-17-5
- PubChem CID: 10634
- ChEBI: 2710
- HMDB: HMDB0003818
- LipidMaps: LMST02020005
- KEGG: C04295
- BioCyc: CPD-23957
- NCBI MeSH: Androstenediol
- Wikipedia: Androstenediol
Other DBLinks
- CAS Registry Number: 16895-59-3
- CAS Registry Number: 19793-20-5
- CAS Registry Number: 521-17-5
- PubChem: 10634
- PubChem: 13215813
- PubChem: 44135378
- ChEBI: ChEBI:2710
- HMDB: HMDB0003818
- LipidMaps: LMST02020005
- KEGG: C04295
- BioCyc: CPD-23957
- NCBI MeSH: Androstenediol
- Wikipedia: Androstenediol
- DrugBank: DB01524
- RefMet: RM0126044
- MoNA: HMDB0003818_c_ms_2049
- MoNA: NGA00361
- MoNA: NGA00362
- MoNA: NGA00363
- MoNA: NGA00364
- Metlin: METLIN_41835
- Coconut NaturalProduct: CNP0294937.1
- Coconut NaturalProduct: CNP0294937.3
- Coconut NaturalProduct: CNP0294937.4
- Coconut NaturalProduct: CNP0294937.7
- Coconut NaturalProduct: CNP0327082.1
- Coconut NaturalProduct: CNP0592534.1
- Coconut NaturalProduct: CNP0592534.2
- Coconut NaturalProduct: CNP0592534.3
- Coconut NaturalProduct: CNP0592534.4
- Coconut NaturalProduct: CNP0606283.1
- Coconut NaturalProduct: CNP0606283.2
- Coconut NaturalProduct: CNP0606283.3
- Coconut NaturalProduct: CNP0606283.4
Class / Ontology
- WishartLab ClassyFire: [Androstane steroids] Androstane steroids
- RefMet: [C19 steroids] C19 steroids
- LipidMaps: [C19 steroids (androgens) and derivatives [ST0202]] C19 steroids (androgens) and derivatives [ST0202]
- ChEBI: [CHEBI:2710] androst-5-ene-3beta,17beta-diol
- Coconut NaturalProduct: [Androstane steroids] Androstane steroids
| ID | EC Number | Name |
|---|---|---|
| KEGG:R02499 | 1.1.1.145 | testosterone delta5-delat4-isomerase; |
| KEGG:R03406 | 1.1.1.51 | androst-5-ene-3beta,17beta-diol:NAD+ oxidoreductase |
| KEGG:R03407 | 1.1.1.51 | androst-5-ene-3beta,17beta-diol:NADP+ oxidoreductase |
| Rhea:RHEA:46205 | androst-5-en-3β,17β-diol + reduced [NADPH—hemoprotein reductase] + O2 => androst-5-en-3β,7α,17β-triol + oxidized [NADPH—hemoprotein reductase] + H2O + H+ | |
| Rhea:RHEA:46206 | androst-5-en-3β,7α,17β-triol + oxidized [NADPH—hemoprotein reductase] + H2O + H+ => androst-5-en-3β,17β-diol + reduced [NADPH—hemoprotein reductase] + O2 | |
| Rhea:RHEA:46207 | androst-5-en-3β,17β-diol + reduced [NADPH—hemoprotein reductase] + O2 <=> androst-5-en-3β,7α,17β-triol + oxidized [NADPH—hemoprotein reductase] + H2O + H+ | |
| Rhea:RHEA:46221 | androst-5-en-3β,17β-diol + NAD+ => 3β-hydroxyandrost-5-en-17-one + NADH + H+ | |
| Rhea:RHEA:46222 | 3β-hydroxyandrost-5-en-17-one + NADH + H+ => androst-5-en-3β,17β-diol + NAD+ | |
| Rhea:RHEA:46223 | androst-5-en-3β,17β-diol + NAD+ <=> 3β-hydroxyandrost-5-en-17-one + NADH + H+ | |
| Rhea:RHEA:46629 | 3β-hydroxyandrost-5-en-17-one + NADPH + H+ => androst-5-en-3β,17β-diol + NADP+ | |
| Rhea:RHEA:46630 | androst-5-en-3β,17β-diol + NADP+ => 3β-hydroxyandrost-5-en-17-one + NADPH + H+ | |
| Rhea:RHEA:46631 | 3β-hydroxyandrost-5-en-17-one + NADPH + H+ <=> androst-5-en-3β,17β-diol + NADP+ | |
| Rhea:RHEA:56933 | androst-5-en-3β,17β-diol + NAD+ => 17β-hydroxy-androst-5-en-3-one + NADH + H+ | |
| Rhea:RHEA:56934 | 17β-hydroxy-androst-5-en-3-one + NADH + H+ => androst-5-en-3β,17β-diol + NAD+ | |
| Rhea:RHEA:56935 | androst-5-en-3β,17β-diol + NAD+ <=> 17β-hydroxy-androst-5-en-3-one + NADH + H+ | |
| BioCyc:RXN-21988 | 1.1.1.145 | CPD-23957 + NAD --> CPD-23979 + NADH + PROTON |
| BioCyc:RXN-21977 | 1.1.1.64 | 3-BETA-HYDROXYANDROST-5-EN-17-ONE + NADPH + PROTON --> CPD-23957 + NADP |